Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcin Barylski

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
American Journal of Rhinology & Allergy|June 30, 2011
Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitisMaciej Ciebiada, Malgorzata Gorska-Ciebiada, Marcin Barylski, et al.
Journal of Cardiovascular Pharmacology|November 7, 2006
Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary preventionJan Kowalski, Marcin Barylski, Maciej Banach, et al.
Angiology|November 20, 2008
Plasma total antioxidant activity in comparison with plasma NO and VEGF levels in patients with metabolic syndromeMarcin Barylski, Edward Kowalczyk, Maciej Banach, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|August 29, 2009
[Estimation of oxidation-reduction balance in subjects with metabolic syndrome together with or without periodontal diseases]Marcin Kowalski, Ewa Brocka, Marcin Barylski, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|August 29, 2009
[Assessment of the periodontal state in subjects with metabolic syndrome]Marcin Kowalski, Ewa Brocka, Marcin Barylski, et al.
Expert Opinion on Therapeutic Targets|February 25, 2009
HSP 70 and atherosclerosis--protector or activator?Agata Bielecka-Dabrowa, Marcin Barylski, Dimitri P Mikhailidis, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 29, 2016
Value of D-dimer and HDL cholesterol concentrations in predicting the occurrence of acute pulmonary embolismJan Kowalski, Jacek Tadeusz Jędrzejczyk, Marcin Barylski, et al.
Current Pharmaceutical Design|September 18, 2013
Statins and new-onset diabetesMarcin Barylski, Dragana Nikolic, Maciej Banach, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 21, 2014
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionalityMarcin Barylski, Peter P Toth, Dragana Nikolic, et al.
Kardiologia Polska|June 10, 2010
[Endothelial dysfunction in hypertension. The role of natriuretic peptides and endothelin]Robert Irzmański, Ewa Serwa-Stepień, Marcin Barylski, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Rhinology & Allergy|June 30, 2011
Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitisMaciej Ciebiada, Malgorzata Gorska-Ciebiada, Marcin Barylski, et al.
Journal of Cardiovascular Pharmacology|November 7, 2006
Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary preventionJan Kowalski, Marcin Barylski, Maciej Banach, et al.
Angiology|November 20, 2008
Plasma total antioxidant activity in comparison with plasma NO and VEGF levels in patients with metabolic syndromeMarcin Barylski, Edward Kowalczyk, Maciej Banach, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|August 29, 2009
[Estimation of oxidation-reduction balance in subjects with metabolic syndrome together with or without periodontal diseases]Marcin Kowalski, Ewa Brocka, Marcin Barylski, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|August 29, 2009
[Assessment of the periodontal state in subjects with metabolic syndrome]Marcin Kowalski, Ewa Brocka, Marcin Barylski, et al.
Expert Opinion on Therapeutic Targets|February 25, 2009
HSP 70 and atherosclerosis--protector or activator?Agata Bielecka-Dabrowa, Marcin Barylski, Dimitri P Mikhailidis, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|May 29, 2016
Value of D-dimer and HDL cholesterol concentrations in predicting the occurrence of acute pulmonary embolismJan Kowalski, Jacek Tadeusz Jędrzejczyk, Marcin Barylski, et al.
Current Pharmaceutical Design|September 18, 2013
Statins and new-onset diabetesMarcin Barylski, Dragana Nikolic, Maciej Banach, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|May 21, 2014
Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionalityMarcin Barylski, Peter P Toth, Dragana Nikolic, et al.
Kardiologia Polska|June 10, 2010
[Endothelial dysfunction in hypertension. The role of natriuretic peptides and endothelin]Robert Irzmański, Ewa Serwa-Stepień, Marcin Barylski, et al.
Pageof 7